Lab diagnostics remains a Cinderella sector. At approximately 2% of healthcare expenditure in most West European countries, it is too small to be of interest to the powerful sales forces and lobbyists from big pharma and big medtech.
Vedici, the French private hospital group where private equity house CVC has a 60% stake, is buying the Polyclinic de la Manche at Saint-Lô and the Clinique du Parc at Caen. The properties are being bought by a French REIT. We hear there was serious competition.
Blackstone, the private equity owner of Vitalia, has yet again put the French private hospital group up for sale. What are its prospects for the group, which Healthcare Europa estimates should have sales of €700m in 2014?
British private hospitals are the most gung-ho in Europe and the Italians the most pessimistic, according to the inaugural Hospital Sentiment Research report, from GE Capital. The report surveyed 380 senior executives in 8 countries (Europe’s top five plus Switzerland, Australia and Japan). Half worked in the private sector.
Social security reimbursements for French lab tests fell 1% in the first seven months of 2014, following a drop of 0.8% for calendar 2013. Does this mean that the government will halt its annual price cut of nearly 3%? Meanwhile, the government has retreated from radical plans, which would have seen a liberalisation of the biologiste profession which controls the lab sector in France.
The French liberal professions have reacted with fury to a set of proposed reforms which would allow private capital to invest in diagnostic labs and pharmacies. Other proposals would end restricted intake, which restricts access to training for dentists and might give a wider role to non-dentists such as hygienists and technicians. The report, compiled in March 2013 by the Inspection Générale des Finances, was only published in September 2014. But does it have a hope in Hell of becoming law?
French occupational and pyschological wellbeing healthcare outfit Stimulus has plans to expand across Europe, following a management buy out backed by Turenne Sante, a specialist fund investing in the French healthcare services sector. We talk to Stimulus CEO David Mahe about his plans.
After years of disappointingly slow growth, has teleradiology, the interpretation of images by radiologists sited remotely, started to turn the corner? Europe’s largest player Telemedicine Clinic (TMC) says it has seen 20-30% compound growth for the past four years. We speak to Alexander Böhmcker, TMC’s CEO, who says even Germany is showing signs of opening up.
Ramsay Health Care, Australia's largest private hospital operator, said on June 11 that it had signed a contract to purchase a 57% stake in Generale de Sante in a deal valuing France's largest hospital group at €945m.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.